Protein & Cell >

2016 , Vol. 7 >Issue 11: 839 - 843

DOI: https://doi.org/10.1007/s13238-016-0325-y

LETTER

3-Anhydro-6-hydroxy-ophiobolin A displays high in vitro and in vivo efficacy against influenza A virus infection

  • Song Wang 1 ,
  • Xiaoqin Luo 1 ,
  • Ruoxiang Yan 1 ,
  • Quanxin Wang 2 ,
  • Qiuyue Qi 2 ,
  • Xiaojuan Chi 1 ,
  • Lanlan Zhang 1 ,
  • Ziding Yu 1 ,
  • Binxiang Cai 1 ,
  • Ji-Long Chen , 1,2 ,
  • Hongwei Liu , 2
Expand
  • 1. College of Animal Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China
  • 2. Institute of Microbiology, Chinese Academy of Sciences, Beijing 100101, China

Published date: 28 Nov 2016

Copyright

2016 The Author(s) 2016. This article is published with open access at Springerlink.com and journal.hep.com.cn
Fold

Cite this article

Song Wang , Xiaoqin Luo , Ruoxiang Yan , Quanxin Wang , Qiuyue Qi , Xiaojuan Chi , Lanlan Zhang , Ziding Yu , Binxiang Cai , Ji-Long Chen , Hongwei Liu . 3-Anhydro-6-hydroxy-ophiobolin A displays high in vitro and in vivo efficacy against influenza A virus infection[J]. Protein & Cell, 2016 , 7(11) : 839 -843 . DOI: 10.1007/s13238-016-0325-y

References

Publishing order | Descend order by publishing year | Descend order by cited within
1
Au TK, Chick WS, Leung PC (2000) The biology of ophiobolins. Life Sci 67:733–742

DOI

2
Cheng PK, Leung TW, Ho EC, Leung PC, Ng AY, Lai MY, Lim WW (2009) Oseltamivir-and amantadine-resistant influenza viruses A (H1N1). Emerg Infect Dis 15:966

DOI

3
Denisova OV, Kakkola L, Feng L, Stenman J, Nagaraj A, Lampe J, Yadav B, Aittokallio T, Kaukinen P, Ahola T (2012) Obatoclax, saliphenylhalamide, and gemcitabine inhibit influenza a virus infection. J Biol Chem 287:35324–35332

DOI

4
Droebner K, Pleschka S, Ludwig S, Planz O (2011) Antiviral activity of the MEK-inhibitor U0126 against pandemic H1N1v and highly pathogenic avian influenza virus in vitro and in vivo. Antiviral Res 92:195–203

DOI

5
Gao R, Cao B, Hu Y, Feng Z, Wang D, Hu W, Chen J, Jie Z, Qiu H, Xu K (2013) Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med 368:1888–1897

DOI

6
Haasbach E, Reiling SJ, Ehrhardt C, Droebner K, Ruckle A, Hrincius ER, Leban J, Strobl S, Vitt D, Ludwig S (2013) The NFkappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus. Antiviral Res 99:336–344

DOI

7
Hurt AC, Holien JK, Parker M, Kelso A, Barr IG (2009) Zanamivirresistant influenza viruses with a novel neuraminidase mutation. J Virol 83:10366–10373

DOI

8
Karlas A, Machuy N, Shin Y, Pleissner KP, Artarini A, Heuer D, Becker D, Khalil H, Ogilvie LA, Hess S (2010) Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature. 463:818–822

DOI

9
Moscona A (2009) Global transmission of oseltamivir-resistant influenza. N Engl J Med 360:953–956

DOI

10
Phuwapraisirisan P, Sawang K, Siripong P, Tip-Pyang S (2007) Anhydrocochlioquinone A, a new antitumor compound from Bipolaris oryzae. Tetrahedron Lett. 48:5193–5195

DOI

11
Planz O (2013) Development of cellular signaling pathway inhibitors as new antivirals against influenza. Antiviral Res 98:457–468

DOI

12
Regoes RR, Bonhoeffer S (2006) Emergence of drug-resistant influenza virus: population dynamical considerations. Science 312:389–391

DOI

13
Wang QX, Yang JL, Qi QY, Bao L, Yang XL, Liu MM, Huang P, Zhang LX, Chen JL, Cai L (2013) 3-Anhydro-6-hydroxyophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae. Bioorg Med Chem Lett 23:3547–3550

DOI

14
Watanabe T, Watanabe S, Kawaoka Y (2010) Cellular networks involved in the influenza virus life cycle. Cell Host Microbe 7:427–439

DOI

15
Yang T, Lu Z, Meng L, Wei S, Hong K, Zhu W, Huang C (2012) The novel agent ophiobolin O induces apoptosis and cell cycle arrest of MCF-7 cells through activation of MAPK signaling pathways. Bioorg Med Chem Lett 22:579–585

DOI

Options
Outlines

/

〈 〉